SpyGlass Pharma, Inc. Common Stock

NASDAQ:SGP

Biotechnology

Healthcare
$29.68 +2.49%

+$0.45 today

Market cap
$993.14M
Beta
-0.34
P/E (TTM)
-14.1
EPS (TTM)
-$1.32
52W Low $17.06High $32.44

Volume 0.10M

Average 0.09M

SGP Gross Profit

Revenue minus cost of revenue: what remains to cover operating expenses after paying for what was sold.

SpyGlass Pharma, Inc. Common StockNASDAQ: SGP

Gross Profit · Q1 FY2026 · quarter ended Mar 2026

Gross profit of -$318K in Q1 FY2026

Q1 FY2026 gross profit was -$318K.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$318K-46.7% QoQ
Last fiscal yearDec 2025
-$612K— YoY
Gross Profit past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Gross Profit history

USD · from the income statement

Latest · FY2025
(612K) USD
Year-over-year change
—

Gross Profit vs competitors

How SGP compares with its peers on the latest reported figures

  • Peers report in different currencies, so gross profit is compared through growth and share of revenue rather than absolute size.
SGP Competitors
Gross Profit for SGP and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ALCAlcon Inc.LTM Sep 2026$6.27B USD+11.6%+6.6%57.3%
BLCOBausch + Lomb CorporationLTM Jun 2026$3.04B USD+9.3%+7.5%57.2%
GKOSGlaukos CorporationLTM Jun 2026$484.88M USD+46.7%+22.5%79.1%
STAASTAAR Surgical CompanyLTM Apr 2026$221.94M USD+7.4%-6.5%76.4%
RXSTRxSight, Inc.LTM Mar 2026$98.18M USD-7.9%+69.0%77.0%
SGHTSight Sciences, Inc.LTM Mar 2026$68.55M USD+2.5%+4.2%86.2%
OCULOcular Therapeutix, Inc.LTM Mar 2026$45.4M USD-16.1%-1.2%87.2%
EYPTEyePoint Pharmaceuticals, Inc.LTM Mar 2026$5.83M USD-88.9%-4.0%76.5%
SGPSpyGlass Pharma, Inc. Common StockFY2025-$612K USD———
OCSOculis Holding AGLTM Mar 2026-CHF 14.56M CHF——2889.4%
Peer median (excluding SGP) —+5.0%+5.4%77.0%

Competitors are the stored peer set for SGP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

SpyGlass Pharma, Inc. Common Stock

NASDAQ:SGP

Intrinsic Alpha fair value

Locked

Current Price

$29.68

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.